NCT07263061
Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries
StatusCompleted
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 7 words Show 6 more changesShow less
- Trial completed
- Primary completion date changed from estimate of Oct 23, 2026 to Aug 10, 2026
- Enrollment target: estimated 1000 to confirmed 936
- Study completion date changed from estimate of Oct 23, 2026 to Aug 17, 2026
- Secondary endpoints: details revised at 3 of 3 entries
- Site details revised
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Nov 24, 2025 to Dec 7, 2025
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Time to recovery of serum albumin as a predictor of outcome in major hepatobiliary surgeries as measured by hospital stay.
Timeframe: 30 days
Secondary (3)
To correlate the time to recovery of albumin with complications and morbidity (Clavien Dindo classification, Comprehensive Complication Index, Intensive Care Unit Stay)
Time to reversal trend of albumin and Hospital stay
correlation of time to recovery of albumin and re admission rates
Arms and interventions
hepatobiliary and pancreatic diseases
Patients undergoing Major Hepato Pancreato biliary surgeries
Other: NO TREATMENT
Sites
1 site in 1 country
- ILBSNew Delhi, National Capital Territory of Delhi, India